Literature DB >> 19023531

Strategies for minimizing corticosteroid toxicity: a review.

Roosy Aulakh1, Surjit Singh.   

Abstract

Glucocorticoids (GCs) are used commonly for the treatment of various pediatric inflammatory and autoimmune diseases. Although potent and generally effective, they are not without risks for producing serious adverse effects, especially when used in high doses for prolonged periods of time. For proper use of systemic glucocortcoids, a basic knowledge of the pharmacology, clinical usage guidelines, and adverse reactions of these agents is imperative. This review article emphasis on the commonly observed side-effects encountered with GC use in children and their underlying basic pathophysiological mechanisms. The appropriate anticipation of these side-effects with timely implementation of the suggested evidencebased guidelines has the potential significantly to prevent, minimize and treat common and disabling complications of glucocortcoid therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19023531     DOI: 10.1007/s12098-008-0211-6

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  15 in total

Review 1.  Minimizing side effects of systemic corticosteroids in children.

Authors:  C T Deshmukh
Journal:  Indian J Dermatol Venereol Leprol       Date:  2007 Jul-Aug       Impact factor: 2.545

Review 2.  Glucocorticoid therapy: minimizing side effects.

Authors:  Carlos Alberto Longui
Journal:  J Pediatr (Rio J)       Date:  2007-11-14       Impact factor: 2.197

3.  Glucocorticoids accelerate ATP loss following metabolic insults in cultured hippocampal neurons.

Authors:  M S Lawrence; R M Sapolsky
Journal:  Brain Res       Date:  1994-05-23       Impact factor: 3.252

Review 4.  Osteoporosis in childhood rheumatic diseases: prevention and therapy.

Authors:  Rolando Cimaz
Journal:  Best Pract Res Clin Rheumatol       Date:  2002-07       Impact factor: 4.098

Review 5.  Ocular effects of topical and systemic steroids.

Authors:  L Renfro; J S Snow
Journal:  Dermatol Clin       Date:  1992-07       Impact factor: 3.478

Review 6.  Glucocorticoid-induced osteoporosis: an update.

Authors:  Gherardo Mazziotti; Alberto Angeli; John P Bilezikian; Ernesto Canalis; Andrea Giustina
Journal:  Trends Endocrinol Metab       Date:  2006 May-Jun       Impact factor: 12.015

Review 7.  Glucocorticoid-induced osteoporosis: pathophysiology and therapy.

Authors:  E Canalis; G Mazziotti; A Giustina; J P Bilezikian
Journal:  Osteoporos Int       Date:  2007-06-14       Impact factor: 4.507

Review 8.  Monitoring adverse reaction to steroid therapy in children.

Authors:  Anju Seth; Anu Aggarwal
Journal:  Indian Pediatr       Date:  2004-04       Impact factor: 1.411

9.  Physiological elevations of glucocorticoids potentiate glutamate accumulation in the hippocampus.

Authors:  B A Stein-Behrens; W J Lin; R M Sapolsky
Journal:  J Neurochem       Date:  1994-08       Impact factor: 5.372

Review 10.  Reactive oxygen species and glucocorticoid-induced hypertension.

Authors:  Sharon L H Ong; Yi Zhang; Judith A Whitworth
Journal:  Clin Exp Pharmacol Physiol       Date:  2008-04       Impact factor: 2.557

View more
  10 in total

1.  Clinical analysis of chinese patients with rheumatoid arthritis treated with leflunomide and methotrexate combined with different dosages of glucocorticoid.

Authors:  Cong-Zhu Ding; Yao Yao; Xue-Bing Feng; Yun Fang; Cheng Zhao; Yue Wang
Journal:  Curr Ther Res Clin Exp       Date:  2012-09

Review 2.  Corticosteroid-use in primary and secondary brain tumour patients: a review.

Authors:  Richella Ryan; Sara Booth; Stephen Price
Journal:  J Neurooncol       Date:  2011-10-05       Impact factor: 4.130

Review 3.  Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives.

Authors:  Sherif A Gaballa; Uday B Kompella; Omar Elgarhy; Ali M Alqahtani; Barbara Pierscionek; Raid G Alany; Hamdy Abdelkader
Journal:  Drug Deliv Transl Res       Date:  2021-06       Impact factor: 4.617

4.  SIRT1 activators suppress inflammatory responses through promotion of p65 deacetylation and inhibition of NF-κB activity.

Authors:  Hongying Yang; Wei Zhang; Heng Pan; Heidi G Feldser; Elden Lainez; Christine Miller; Stewart Leung; Zhong Zhong; Huizhen Zhao; Sharon Sweitzer; Thomas Considine; Thomas Riera; Vipin Suri; Brian White; James L Ellis; George P Vlasuk; Christine Loh
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

5.  Dexamethasone Treatment at the Myoblast Stage Enhanced C2C12 Myocyte Differentiation.

Authors:  Der-Sheng Han; Wei-Shiung Yang; Tung-Wei Kao
Journal:  Int J Med Sci       Date:  2017-04-08       Impact factor: 3.738

6.  Evaluation of Urinary Tract Infection following Corticosteroid Therapy in Patients with Multiple Sclerosis Exacerbation.

Authors:  Aliyeh Bazi; Seyed Mohammad Baghbanian; Monireh Ghazaeian; Sahar Fallah; Narjes Hendoiee
Journal:  Can J Infect Dis Med Microbiol       Date:  2021-01-31       Impact factor: 2.471

7.  Clinical comparisons between previously diagnosed SLE and newly diagnosed SLE by kidney biopsy.

Authors:  Pantipa Tonsawan; Kittisak Sawanyawisuth
Journal:  Auto Immun Highlights       Date:  2020-12-02

8.  A National Consensus Survey for Current Practice in Brain Tumor Management I: Antiepileptic Drug and Steroid Usage.

Authors:  Sung Kwon Kim; Jangsup Moon; Jin Mo Cho; Chul Kee Park; Youn Soo Lee; Ho Shin Gwak; Kyung Hwan Kim; Se Hoon Kim; Young Il Kim; Young Zoon Kim; Ho Sung Kim; Yun Sik Dho; Jae Sung Park; Ji Eun Park; Youngbeom Seo; Kyoung Su Sung; Jin Ho Song; Chan Woo Wee; Wan Soo Yoon; Hong In Yoon; Se Hoon Lee; Do Hoon Lim; Jung Ho Im; Jong Hee Chang; Myung Hoon Han; Je Beom Hong; Kihwan Hwang
Journal:  Brain Tumor Res Treat       Date:  2020-04

9.  Polyphenols Extracted from Shanxi-Aged Vinegar Inhibit Inflammation in LPS-Induced RAW264.7 Macrophages and ICR Mice via the Suppression of MAPK/NF-κB Pathway Activation.

Authors:  Peng Du; Jia Song; Huirui Qiu; Haorui Liu; Li Zhang; Junhan Zhou; Shengping Jiang; Jinyu Liu; Yu Zheng; Min Wang
Journal:  Molecules       Date:  2021-05-07       Impact factor: 4.411

10.  Therapeutic and Prognostic Implications of Immune-Related Adverse Events in Advanced Non-Small-Cell Lung Cancer.

Authors:  Lea Daniello; Mariam Elshiaty; Farastuk Bozorgmehr; Jonas Kuon; Daniel Kazdal; Hannah Schindler; Rajiv Shah; Anna-Lena Volckmar; Fabienne Lusky; Leonore Diekmann; Stephan Liersch; Martin Faehling; Thomas Muley; Mark Kriegsmann; Karolina Benesova; Albrecht Stenzinger; Michael Thomas; Petros Christopoulos
Journal:  Front Oncol       Date:  2021-06-29       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.